Annie R. Piñeros
Eli Lilly (United States)(US)The Ohio State University Wexner Medical Center(US)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes and associated disorders, Immune Response and Inflammation, Immune Cell Function and Interaction, Tuberculosis Research and Epidemiology
Most-Cited Works
- → IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population(2017)225 cited
- → Sepsis expands a CD39+ plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity(2021)109 cited
- → Role of orally induced regulatory T cells in immunotherapy and tolerance(2020)83 cited
- → Deoxyhypusine synthase promotes a pro-inflammatory macrophage phenotype(2021)59 cited
- → Hypusine biosynthesis in β cells links polyamine metabolism to facultative cellular proliferation to maintain glucose homeostasis(2019)56 cited
- → A Versatile, Portable Intravital Microscopy Platform for Studying Beta-cell Biology In Vivo(2019)53 cited
- → Green propolis increases myeloid suppressor cells and CD4+Foxp3+ cells and reduces Th2 inflammation in the lungs after allergen exposure(2019)53 cited
- → SOCS1 is a negative regulator of metabolic reprogramming during sepsis(2017)44 cited
- → M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection(2017)39 cited
- → Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes(2022)38 cited